Trial intelligence / Profile preview

Alphagan-P for Subconjunctival Hemorrhage in FLACS

NCT04633954Completed

Sponsor
Uptown Eye Specialists
Start
Jun 2019
Primary completion
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of brimonidine in subconjunctival hemorrhage (SCH) (2 arms), sponsored by Uptown Eye Specialists. Primary endpoint: Bulbar Redness. Started Jun 2019; status: completed.

02

Drugs

brimonidine
03

Conditions

subconjunctival hemorrhage (SCH)

Beyond the preview

Go deeper on NCT04633954.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04633954.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call